LITS · Lite Strategy, Inc.
$0.97
+0.00 (+0.28%)
At close · Jul 29
Market Cap
$33.00M
Shares
34.03M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2025
Net Income
-$15.95M
-189.7%
FY2025
Gross Margin
100%
+4pp
FY2022
Operating Margin
22.27%
+97.6pp
FY2024
Diluted EPS
-$2.39
-189.5%
FY2025
Operating Cash Flow
-$20.84M
+58.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $0 | $65.3M | $48.82M | $40.7M | $34.8M | $28.91M | $4.92M | $1.62M | $23.25M | — | — | — | — | — | |
| — | — | — | — | $0 | $1.41M | $2.67M | $4.26M | — | — | — | — | — | — | — | |
| — | — | — | — | $40.7M | $33.39M | $26.24M | $652K | — | — | — | — | — | — | — | |
| — | — | — | — | 100% | 95.95% | 90.76% | 13.27% | — | — | — | — | — | — | — | |
| $169K | $3.92M | $16.56M | $52.45M | $85.64M | $69.4M | $34.07M | $32.3M | $17.04M | $7.24M | $13.4M | $23.82M | $19.33M | $50.19M | $44.1M | |
| $11.93M | $13.53M | $23.3M | $33.13M | $30.54M | $24.41M | $16.72M | $14.6M | $9.79M | $8.63M | $7.6M | $8.95M | $7.9M | $27.91M | $22.77M | |
| — | — | — | — | — | $0 | $34K | $35K | $35K | $35K | $35K | $34K | $35K | — | — | |
| — | $368K | $383K | $386K | $326K | $285K | $109K | $80K | $53K | $85K | $58K | $64K | $50K | $71K | — | |
| — | — | — | — | — | — | — | — | — | — | $21M | $32.77M | $27.23M | $99.6M | $88.37M | |
| $58.09M | $17.46M | $50.76M | $85.58M | $116.18M | $95.22M | $53.45M | $51.16M | $30.21M | $20.87M | — | — | — | — | — | |
| -$58.09M | -$17.46M | $14.54M | -$36.76M | -$75.48M | -$60.42M | -$24.54M | -$46.25M | -$28.59M | $2.38M | -$21M | -$32.77M | -$27.23M | -$99.6M | -$88.37M | |
| — | — | 22.27% | -75.31% | -185.48% | -173.65% | -84.88% | -940.9% | -1762.39% | 10.25% | — | — | — | — | — | |
| — | -$17.09M | $14.93M | -$36.38M | -$75.16M | -$60.14M | -$24.43M | -$46.17M | -$28.53M | $2.47M | -$20.95M | -$32.71M | -$27.18M | -$99.53M | — | |
| -$2.73M | $1.51M | $3.24M | $4.93M | $21.03M | $486K | — | — | — | — | — | — | — | — | $871K | |
| — | — | — | — | — | — | — | — | — | — | — | — | $100K | $100K | $100K | |
| — | -$15.95M | $17.78M | -$31.84M | -$54.45M | -$41.31M | -$46.02M | -$16.82M | -$40.07M | $2.67M | -$20.86M | -$32.69M | -$27.15M | -$11.19M | -$7.52M | |
| — | $0 | $0 | $0 | $0 | $8000 | $1000 | $1000 | $1000 | $1000 | $1000 | $1000 | $1000 | $11K | $10K | |
| -$60.82M | -$15.95M | $17.78M | -$32M | -$54.45M | -$41.31M | -$46.02M | -$16.82M | -$40.07M | $2.67M | -$20.86M | -$32.69M | -$27.15M | -$11.19M | -$7.52M | |
| — | — | 27.23% | -65.55% | -133.8% | -118.73% | -159.15% | -342.2% | -2470.28% | 11.48% | — | — | — | — | — | |
| — | — | — | -$31.84M | -$54.45M | -$41.31M | -$46.02M | -$16.82M | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | -$11.19M | -$7.52M | |
| USD/shares | — | -$2.39 | $2.67 | -$4.78 | -$8.80 | -$7.40 | -$10.20 | -$4.80 | -$19.40 | $1.40 | — | — | — | — | — |
| USD/shares | — | -$2.39 | $2.67 | -$4.78 | -$10.00 | -$12.00 | -$10.20 | -$15.00 | -$19.40 | $1.40 | — | — | — | — | — |
| shares | — | 6.66M | 6.66M | 6.66M | 6.22M | 5.63M | 4.55M | 3.56M | 2.07M | 1.84M | 1.72M | 1.41M | 1M | 508.04K | 674.31K |
| shares | — | 6.66M | 6.66M | 6.66M | 6.26M | 5.72M | 4.55M | 3.62M | 2.07M | 1.85M | 1.72M | 1.41M | 1M | 508.04K | 674.31K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2025: $11.66M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 11.85×
EV/EBIT
—
P/E (TTM)
—
Peer median 1.05×
Peer medians compare against the 269 similar-size Biotechnology companies (of 522 listed).